Hematology
Published on May 28, 2025.
Updated on January 27, 2026.
Whether supporting early-stage strategy, preparing for launch, or monitoring in-market performance, we help clients cut through complexity to anticipate trends and identify opportunities.
Core focus areas
- Multiple Myeloma (MM)
- Leukemia (CLL/AML)
- Lymphoma (DLBCL/MCL/FL/MZL/HL/ALCL)
- Myelofibrosis (MF)
- Myelodysplastic Syndrome (MDS)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Beta-Thalassemia
- Hemophilia A & B
- ITP (Immune Thrombocytopenic Purpura)








